Bath & Body Works (NYSE:BBWI) Sets New 52-Week Low - Time to Sell?

Bath & Body Works, Inc. (NYSE:BBWI - Get Free Report) shares hit a new 52-week low during mid-day trading on Friday . The company traded as low as $25.84 and last traded at $26.36, with a volume of 630228 shares changing hands. The stock had previously closed at $27.85.

Wall Street Analysts Forecast Growth

A number of research firms have commented on BBWI. Cowen restated a "buy" rating on shares of Bath & Body Works in a research note on Thursday, February 27th. JPMorgan Chase & Co. set a $47.00 price target on Bath & Body Works in a research report on Thursday, February 27th. Piper Sandler increased their price target on Bath & Body Works from $36.00 to $39.00 and gave the stock a "neutral" rating in a report on Monday, January 6th. Argus reiterated a "hold" rating on shares of Bath & Body Works in a research report on Friday, January 10th. Finally, Raymond James restated an "outperform" rating and set a $46.00 target price (up from $42.00) on shares of Bath & Body Works in a research report on Tuesday, February 25th. Five research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $45.06.

Bath & Body Works Stock Performance

The firm has a market capitalization of $5.64 billion, a P/E ratio of 6.38, a P/E/G ratio of 0.92 and a beta of 1.69. The stock has a fifty day moving average price of $34.45 and a two-hundred day moving average price of $34.16.

Remove Ads

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings results on Thursday, February 27th. The company reported $2.09 EPS for the quarter, beating the consensus estimate of $2.04 by $0.05. The business had revenue of $2.79 billion during the quarter, compared to analyst estimates of $2.78 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. As a group, research analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Investors of record on Friday, February 21st were issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 3.04%. The ex-dividend date was Friday, February 21st. Bath & Body Works's dividend payout ratio (DPR) is 21.98%.

Bath & Body Works announced that its Board of Directors has authorized a share repurchase program on Thursday, February 27th that authorizes the company to repurchase $500.00 million in shares. This repurchase authorization authorizes the company to repurchase up to 6.4% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company's management believes its stock is undervalued.

Hedge Funds Weigh In On Bath & Body Works

A number of institutional investors and hedge funds have recently added to or reduced their stakes in BBWI. Golden State Wealth Management LLC acquired a new stake in shares of Bath & Body Works in the fourth quarter valued at $26,000. SRS Capital Advisors Inc. raised its holdings in shares of Bath & Body Works by 99.7% in the 4th quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock worth $26,000 after purchasing an additional 329 shares in the last quarter. UMB Bank n.a. lifted its position in shares of Bath & Body Works by 58.8% during the 4th quarter. UMB Bank n.a. now owns 905 shares of the company's stock valued at $35,000 after acquiring an additional 335 shares during the last quarter. Lindbrook Capital LLC lifted its holdings in shares of Bath & Body Works by 81.9% during the fourth quarter. Lindbrook Capital LLC now owns 957 shares of the company's stock valued at $37,000 after purchasing an additional 431 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB purchased a new position in Bath & Body Works in the 3rd quarter worth about $39,000. 95.14% of the stock is owned by institutional investors.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.